Abstract:The tumor suppressor F-box protein 31 (FBXO31) is indispensable for maintaining genomic stability. Its levels drastically increase following DNA damage, leading to cyclin D1 and MDM2 degradation and G1 and G2/M arrest. Prolonged arrest in these phases leads to cellular senescence. Accordingly, FBXO31 needs to be kept at low basal levels in unstressed conditions for normal cell cycle progression during growth and development. However, the molecular mechanism maintaining these basal FBXO31 levels has remained unclear. Here, we identified the F-box family SCF-E3 ubiquitin ligase FBXO46 (SCFFBXO46) as an important proteasomal regulator of FBXO31 and found that FBXO46 helps maintain basal FBXO31 levels under unstressed conditions and thereby prevents premature senescence. Using molecular docking and mutational studies, we showed that FBXO46 recognizes an RXXR motif located at the FBXO31 C terminus to direct its polyubiquitination and thereby proteasomal degradation. Furthermore, FBXO46 depletion enhanced the basal levels of FBXO31, resulting in senescence induction. In response to genotoxic stress, ATM (ataxia telangiectasia-mutated) Ser/Thr kinase-mediated phosphorylation of FBXO31 at Ser-278 maintained FBXO31 levels. In contrast, activated ATM phosphorylated FBXO46 at Ser-21/Ser-67, leading to its degradation via FBXO31. Thus, ATM-catalyzed phosphorylation after DNA damage governs FBXO31 levels and FBXO46 degradation via a negative feedback loop. Collectively, our findings reveal that FBXO46 is a crucial proteasomal regulator of FBXO31 and thereby prevents senescence in normal growth conditions. They further indicate that FBXO46-mediated regulation of FBXO31 is abrogated following genotoxic stress to promote increased FBXO31 levels for maintenance of genomic stability.

FBXW7 inactivation induces cellular senescence via accumulation of p53

FBXW7 Confers Radiation Survival by Targeting P53 for Degradation

Clinical significance of FBXW7 loss of function in human cancers

The SCFFBXO46 ubiquitin ligase complex mediates degradation of the tumor suppressor FBXO31 and thereby prevents premature cellular senescence

FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.

WW Domain-containing E3 Ubiquitin Protein Ligase 1 (WWP1) Delays Cellular Senescence by Promoting p27Kip1 Degradation in Human Diploid Fibroblasts

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence

FBXW7 in Cancer: What Has Been Unraveled Thus Far?

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

The Atypical E2F Family Member E2F7 Couples the P53 and RB Pathways During Cellular Senescence.

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

FBXO46 negatively regulates p53 activity by stabilizing Mdm2

FBW7 Suppresses Cell Proliferation and G2/M Cell Cycle Transition Via Promoting Γ-Catenin K63-linked Ubiquitylation.

FBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping

Foxp3 is a key downstream regulator of p53-mediated cellular senescence

Chemokine Receptor CXCR2 is Transactivated by P53 and Induces P38‐mediated Cellular Senescence in Response to DNA Damage

Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation

Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair

FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy